Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 1,688.9 | 1,334.1 | 3,975.0 | 3,867.0 | 3,867.0 | 3,598.5 | 3,373.4 | 2,960.9 |
| Revenue growth | 26.6% | -66.4% | 2.8% | 7.5% | | 6.7% | 13.9% | 12.5% |
| Cost of goods sold | 691.5 | 579.0 | 1,726.2 | 1,654.4 | 2,791.4 | 2,513.9 | 2,287.7 | 1,944.1 |
| Gross profit | 997.4 | 755.1 | 2,248.8 | 2,212.6 | 1,075.5 | 1,084.6 | 1,085.7 | 1,016.8 |
| Gross margin | 59.1% | 56.6% | 56.6% | 57.2% | 27.8% | 30.1% | 32.2% | 34.3% |
| Selling, general and administrative | 2,273.0 | 2,329.5 | 2,485.6 | 2,202.5 | 513.5 | 510.1 | 626.2 | 557.1 |
| General and administrative | 1,052.8 | 1,156.7 | 1,285.2 | 1,098.6 | | | | |
| EBITA | -601.8 | -924.6 | 430.5 | 632.6 | 562.0 | 673.1 | 605.4 | 581.6 |
| EBITA margin | -35.6% | -69.3% | 10.8% | 16.4% | 14.5% | 18.7% | 17.9% | 19.6% |
| Amortization of intangibles | 64.0 | 66.0 | 65.0 | 68.0 | | 96.0 | 143.0 | 107.0 |
| EBIT | -665.8 | -990.6 | 365.5 | 564.6 | 562.0 | 577.1 | 462.4 | 474.6 |
| EBIT margin | -39.4% | -74.2% | 9.2% | 14.6% | 14.5% | 16.0% | 13.7% | 16.0% |
| Pre-tax income | -938.4 | -1,304.9 | 199.6 | 398.4 | 398.4 | 377.6 | 328.0 | 353.9 |
| Income taxes | -14.6 | -21.0 | 35.3 | 57.5 | 57.5 | 128.0 | 86.6 | 119.4 |
| Tax rate | 1.6% | 1.6% | 17.7% | 14.4% | 14.4% | 33.9% | 26.4% | 33.7% |
| Earnings from continuing ops | -947.5 | -1,292.8 | 160.4 | 335.8 | 340.9 | 494.0 | 237.0 | 231.1 |
| Earnings from discontinued ops | -2.5 | 2.8 | -1.8 | 1.7 | 1.7 | -1.9 | 5.5 | 314.4 |
| Net income | -950.1 | -1,290.0 | 158.6 | 337.5 | 342.7 | 492.1 | 242.6 | 545.5 |
| Net margin | -56.3% | -96.7% | 4.0% | 8.7% | 8.9% | 13.7% | 7.2% | 18.4% |
| |
| Diluted EPS | ($2.95) | ($4.46) | $0.58 | $1.21 | $1.23 | $1.78 | $0.84 | $0.83 |
| Shares outstanding (diluted) | 320.9 | 289.9 | 276.2 | 277.5 | 277.5 | 278.3 | 282.8 | 280.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|